These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22004671)

  • 41. Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry.
    Bodor GS
    Clin Lab Med; 2018 Sep; 38(3):455-470. PubMed ID: 30115391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.
    Huestis MA
    Clin Chem; 2009 Dec; 55(12):2079-81. PubMed ID: 19833833
    [No Abstract]   [Full Text] [Related]  

  • 43. Selection of an immunoassay screening cutoff concentration for opioids in oral fluid.
    Garnier M; Coulter C; Moore C
    J Anal Toxicol; 2011 Jul; 35(6):369-74. PubMed ID: 21740695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry.
    Ristimaa J; Gergov M; Pelander A; Halmesmäki E; Ojanperä I
    Anal Bioanal Chem; 2010 Sep; 398(2):925-35. PubMed ID: 20617307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic Pain.
    Snyder ML; Fantz CR; Melanson S
    Pain Physician; 2017 Feb; 20(2S):SE1-SE9. PubMed ID: 28226337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry.
    Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
    Anal Bioanal Chem; 2008 Jul; 391(6):2329-38. PubMed ID: 18483722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC-MS-MS.
    Truver MT; Swortwood MJ
    J Anal Toxicol; 2018 Oct; 42(8):554-561. PubMed ID: 30371839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urine and oral fluid drug testing in support of pain management.
    Kwong TC; Magnani B; Moore C
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):433-445. PubMed ID: 28990451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A simple validated multi-analyte method for detecting drugs in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
    Zheng Y; Sparve E; Bergström M
    Drug Test Anal; 2018 Jun; 10(6):1001-1008. PubMed ID: 29044958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Drugs in Simultaneously Collected Samples of Oral Fluid and Blood.
    Bakke E; Høiseth G; Arnestad M; Gjerde H
    J Anal Toxicol; 2019 Apr; 43(3):228-232. PubMed ID: 30295809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction.
    Kunkel F; Fey E; Borg D; Stripp R; Getto C
    J Opioid Manag; 2015; 11(5):435-42. PubMed ID: 26535971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose.
    Griswold MK; Chai PR; Krotulski AJ; Friscia M; Chapman BP; Varma N; Boyer EW; Logan BK; Babu KM
    J Med Toxicol; 2017 Dec; 13(4):287-292. PubMed ID: 28971325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid.
    Grabenauer M; Moore KN; Bynum ND; White RM; Mitchell JM; Hayes ED; Flegel R
    J Anal Toxicol; 2018 Jul; 42(6):392-399. PubMed ID: 29554298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder.
    Arvidsson M; Ullah S; Franck J; Dahl ML; Beck O
    Drug Test Anal; 2019 Jan; 11(1):27-32. PubMed ID: 29575801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive Value of Positive Drug Screening Results in an Urban Outpatient Population.
    Bertholf RL; Sharma R; Reisfield GM
    J Anal Toxicol; 2016 Nov; 40(9):726-731. PubMed ID: 27550994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.